These findings are highly significant, given that the recommended treatment for TB involves a combination of drugs with various mechanisms of action.
← all excerpts
Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> approaches.
1
—
—